Translational Development Acquisition Corp. TDAC FINANCIAL
Company Overview
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Why Investors Should Care
Carries low leverage with a debt-to-equity ratio of 0.11.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -40.6%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -40.60% |
Stock Price Performance
| 1 Year: | +5.43% |
| 6 Months: | +3.23% |
| 3 Months: | +1.12% |
| 1 Month: | +0.18% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)68.28 · Neutral
P/E of 41.85 is above the sector median of 12.89 — pricier than peers.
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
No notable concerns flagged.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Financial Services).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TDAC Translational Development Acquisition Corp. FINANCIAL | 10.88 | 41.85 | $210.08M | 0.00% | -0.52% | 3.63% | - | - |
| 2 | JPM JPMorgan Chase & Co. SPXR3KFINANCIAL | 353.51 | 15.15 | $939.70B | 1.72% | - | 17.79% | 12.50% | 14.83% |
| 3 | BRK-B Berkshire Hathaway Inc. SPXFINANCIAL | 505.83 | 12.72 | $712.23B | 0.00% | - | 12.12% | 4.18% | 9.44% |
| 4 | V Visa Inc. SPXR3KFINANCIAL | 368.64 | 31.35 | $628.20B | 0.72% | 37.15% | 61.19% | 14.33% | 13.04% |
| 5 | MA Mastercard Incorporated SPXR3KFINANCIAL | 570.89 | 31.44 | $496.37B | 0.62% | 60.19% | - | 12.29% | 19.21% |
| 6 | BAC Bank of America Corporation SPXR3KFINANCIAL | 62.39 | 14.41 | $436.28B | 2.04% | - | 11.20% | 3.14% | 4.27% |
| 7 | BRK-A Berkshire Hathaway Inc. FINANCIAL | 757,791.00 | 12.71 | $370.14B | 0.00% | - | 12.12% | 7.60% | 10.02% |
| 8 | HSBC HSBC Holdings plc FINANCIAL | 106.26 | 15.18 | $363.70B | 3.65% | - | 13.10% | 9.75% | 12.72% |
| 9 | MS Morgan Stanley SPXR3KFINANCIAL | 216.24 | 17.48 | $339.62B | 2.26% | - | 17.97% | 3.76% | 9.66% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | 347.41K | 221.13K | 213.66K | 162.34K | 281.16K |
| Operating Income | 0 | -1.69K | -61.28K | -347.41K | -221.13K | -213.66K | -162.34K | -281.16K |
| EBITDA | - | - | - | -347.41K | -221.13K | -213.66K | -162.34K | -281.16K |
| Interest Expense | - | - | - | - | - | - | - | - |
| Pretax Income | - | - | - | 1.48M | 1.62M | 1.66M | 1.60M | 1.33M |
| Tax Provision | - | - | - | - | - | - | - | - |
| Net Income | 0 | -1.69K | -61.28K | 1.48M | 1.62M | 1.66M | 1.60M | 1.33M |
| Diluted EPS | - | - | - | 0.07 | 0.07 | 0.08 | - | 0.06 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Revenue | 0 | 0 | 0 |
| Cost of Revenue | - | - | - |
| Gross Profit | - | - | - |
| Operating Expenses | 485.55K | 196.36K | 944.54K |
| Operating Income | -485.55K | -196.36K | -944.54K |
| EBITDA | -485.55K | -196.36K | -944.54K |
| Interest Expense | - | - | - |
| Pretax Income | -485.55K | -71.01K | 6.36M |
| Tax Provision | - | - | - |
| Net Income | -485.55K | -71.01K | 6.36M |
| Diluted EPS | -0.11 | -0.02 | 0.29 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Total Assets | 437.24K | 2.02K | 175.00M | 181.70M |
| Current Assets | 54.23K | 2.02K | 650.23K | 39.47K |
| Cash & Equivalents | 2.23K | 2.02K | 438.17K | 29.79K |
| Inventory | - | - | - | - |
| Receivables | - | - | - | - |
| Total Liabilities | 459.34K | 509.68K | 6.25M | 6.58M |
| Current Liabilities | 459.39K | 509.68K | 210.30K | 544.07K |
| Long Term Debt | - | - | - | - |
| Total Debt | 259.00K | 347.50K | - | 200.00K |
| Total Equity | -22.11K | -507.66K | 168.75M | 175.12M |
| Shares Outstanding | 19.66M | 19.66M | 21.91M | 21.91M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Operating Cash Flow | -204 | -851.45K | -608.39K |
| Investing Cash Flow | 0 | -174.22M | 0 |
| Financing Cash Flow | 0 | 175.51M | 200.00K |
| Capital Expenditure | - | - | - |
| Free Cash Flow | -204 | -851.45K | -608.39K |
| Net Change in Cash | -204 | 436.15K | -408.39K |
Ratios (Annual)
Figures in %.
| Metric | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|
| Gross Margin % | - | - | - |
| Operating Margin % | - | - | - |
| Net Margin % | - | - | - |
| ROE % | 95.6% | -0.0% | 3.6% |
| ROCE % | 95.6% | -0.1% | -0.5% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Linden Advisors LP | 6.67% | 1.15M | $12.48M |
| 2 | Kryger Capital LLC | 6.61% | 1.14M | $12.38M |
| 3 | Magnetar Financial LLC | 5.80% | 1.00M | $10.85M |
| 4 | AQR Arbitrage LLC | 5.65% | 974.30K | $10.57M |
| 5 | Wolverine Asset Management, LLC | 5.48% | 944.88K | $10.25M |
| 6 | Meteora Capital, LLC | 5.33% | 919.00K | $9.97M |
| 7 | Highbridge Capital Management, LLC. | 5.00% | 861.84K | $9.35M |
| 8 | LMR Partners LLP | 4.64% | 800.00K | $8.68M |
| 9 | Tenor Capital Management Co., L.p. | 3.68% | 635.40K | $6.89M |
| 10 | Alberta Investment Management Corp | 3.48% | 600.00K | $6.51M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for TDAC
Discipline and Rules-Based Execution in TDAC Response - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMizgFBVV95cUxQVXpBcEo3MkxJTzZ6cHRLWS1CSm52SFlla3RYRlRqVVNNR1VubEgzQ2JCbmFlNHZUZ25LeE5QQWppQWFOQjJQUGdhX3Q4OVF5QUZWZWh1RkI1SGZoYnBhTnlCRklWd2xXcTRROUQ3TmY1VGhiTjBFTUdNbzdwOFl5SlN3YkJKVnNGcjZaaV…
Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPb3FlNnQzc09jVDllV1ZlUHZIQmh2aktoZzhkZ2pVZ0FzVnZ4WEtFOGVkTDQ3a1Y1MklXaFh1RmhhbHlQYUVWeGRSLXVmNGwtdGQtS09WdDBDZnpBZ1NNU05adWtSSDdiR2ctSERJYlVNaG80bk9iR3pVYjhZVnBTYllmWk5QU25RVDFkV1…
TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNMXNjcl9XQ0pZMmozeDU1NDJSUVF2UDVmWE5VUWtwZ2p0VHJTSDFjSUg4X3hwWUJmZURSeFY2Y3N0aWlIdGVLQlVUSk5YUHdkWlFzbkpHQlBJM1pqdkdwcUN2azNmbWd4LVZWNDdsbFEtckRiUjJFay1LeXRlMVN0MGd2YS1tWHZsM2FTYX…
TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote - Morningstar
<a href="https://news.google.com/rss/articles/CBMi5AFBVV95cUxNaEtWdEdfbFhRc0lWMVgxcFdyWUVpSnV6dV9oOVBocHJOU2p6dWdzNlhzeEk2UG0zUWp6amQtejJOMHJEcmRFMExlYWh0cHM5blo1TDA0aEpoUkNqWjBJUUNVRVVJVW5iUFd1TGU0cVYxajNvRlFaRzVWMkVteUdjZlA0cVJ0Y1MyWGY2N2…
ProLogium to list on Nasdaq via TDAC merger at $3.8B valuation - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxPeEM0N25WTDd5VU5PM3RHOUlFTzlhN2hmdnYwblFlc01NbUV6QzAzX3pzODZMRlhxYWNqanhGRXg5WFRPVUtWWjdwX3lVRVV3eXR4Y0UtdTBINHp3OTh5WWppWWkwVElZVHdfYmRscGRJbldzdnhSQ1ZLWFQzOVJsc0N1ZW5sVmFPRnFBcX…
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - WEAV, BRBS, TDAC and UHG - Sahm
<a href="https://news.google.com/rss/articles/CBMi7gFBVV95cUxPLVhZRFFqN3FyWDZqdU1Nbld1NEVFbDU4bFdLRzBXblU3UDZHa2FZMjVkd24zZVRLRXNWakcwQTgwWXZpWlJROGdPb2xZMXo1YmxMN2FNZWlvUzQ5SVhMclc5LXRoODdTSUJjalNvRnIzUVdDcG9tVHc3aldmRFlHMWNHRHdJX2VMNFBIUW…
TDAC — Frequently Asked Questions
What is the current share price of Translational Development Acquisition Corp. (TDAC)?
As of 2026-09-19 21:16 PDT, Translational Development Acquisition Corp. (TDAC) trades at $10.88 on NasdaqGM. Its 52-week range is $10.32 to $10.88.
What is the market capitalisation of TDAC?
Translational Development Acquisition Corp. (TDAC) has a market capitalisation of $210.08M on NasdaqGM.
What is the P/E ratio of TDAC?
TDAC trades at a trailing price-to-earnings (P/E) ratio of 41.85. The industry average P/E is 12.89. Its price-to-book (P/B) ratio is -27.26.
What is the return on equity (ROE) of TDAC?
TDAC has a return on equity (ROE) of 3.63%. Its return on capital employed (ROCE) is -0.52%.
Is TDAC a good stock to buy?
This page provides a data-driven analysis of Translational Development Acquisition Corp. (TDAC), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.